Robert Pelzer
Vancouver-based biopharma company Qu Biologics has appointed the former President of Novartis Robert Pelzer to its board of directors.
“Bob Pelzer’s wealth of leadership experience with Novartis and DuPont will be invaluable to Qu Biologics during this important stage of our growth and development, as we advance our clinical trial in Crohn’s disease and develop relationships with potential pharma partners,” said Qu Biologics CEO Dr. Hal Gunn.